Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease (Sep 2019)

Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia (Sep 2019)

Intrathecal administration of autologous mesenchymal stem cells in multiple system atrophy (Jul 2019)

Early Results of a Phase I Trial Using an Adipose-Derived Mesenchymal Stem Cell-Coated Fistula Plug for the Treatment of Transsphincteric Cryptoglandular Fistulas (May 2019)